Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients

NCT04673162 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

260

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19

Interventions

DRUG: Methylprednisolone, Placebo

Sponsor

Azienda USL Reggio Emilia - IRCCS